Meena Gorowara

Pharmacokinetics and 48-Week Efficacy of Nevirapine: 400 mg Versus 600 mg per day in HIV–Tuberculosis Coinfection Receiving Rifampicin

Anchalee Avihingsanon, Weerawat Manosuthi, Pacharee Kantipong et al. · Antiviral Therapy · 2008 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral Contraceptives

Nadia Kancheva Landolt, Nittaya Phanuphak, Sasiwimol Ubolyam et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 42 citations

Medicine, Pharmacokinetics, Pharmacology +16

A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate Pharmacokinetic Parameters in HIV-1-Infected Thai Adults

Anchalee Avihingsanon, Jasper van der Lugt, Meena Gorowara et al. · Clinical Pharmacology & Therapeutics · 2008 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals

Jasper van der Lugt, Joep M. A. Lange, Anchalee Avihingsanon et al. · Antiviral Therapy · 2008 · 23 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy

Reshmie Ramautarsing, Jasper van der Lugt, Meena Gorowara et al. · AIDS · 2011 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +16